News

Essex Bio-Technology joins X-ZELL Seed+ Investment Round

Singapore/Hong Kong, April 2020 – Rare cell detection specialist X-ZELL has entered into an investment agreement with Essex Bio-Investment, a wholly owned subsidiary of Essex Bio-Technology Ltd (“EssexBio”). Ranked amongst Asia’s 50 most innovative health technology...

X-ZELL featured in German life science magazine Laborjournal

Freiburg, April 2020 – X-ZELL has been featured in the April edition of Laborjournal, one of Germany’s leading life science publications.    The extensive company profile, penned by science journalist Dr Sigrid März, outlines X-ZELL’s rapid ascent from a small Bangkok...

Interview: Krebs im Blut

Due to the overwhelming response to X-ZELL’s recent Live Sessions tour around Germany, we sat down with X-ZELL Founder & CEO, Dr Sebastian Bhakdi, to interview him in his native language.  Singapur, Februar 2020 – Der deutsche Arzt Dr. Sebastian Bhakdi (44) ist...

X-ZELL Cryoimmunostaining™ technology touring Europe

Brussels, February 2020 – Following the official European launch of X-ZELL’s Cryoimmunostaining™ Suite in November 2019, the Singapore start-up will be holding a series of Live Sessions in 2020 in order to introduce the new technology to some of the leading minds in...

X-ZELL selected as Finalist for 2020 Hello Tomorrow Global Challenge

Singapore, January 2020 – Singapore med tech start-up, X-ZELL, has been nominated as a Global Finalist for the 2020 Hello Tomorrow Challenge.  Considered one of the world’s leading deep tech start-up competitions, the Challenge was created to celebrate the “best and...

X-ZELL named global Deep Tech Pioneer by Hello Tomorrow

Singapore, November 2019 – On the back of qualifying for the regional final of the prestigious Hello Tomorrow Challenge, X-ZELL has now been selected as one of Hello Tomorrow’s Deep Tech Pioneers. According to the competition’s organising committee, it received a...

X-ZELL Cryoimmunostaining™ Suite now available in Europe

Singapore, November 2019 – Less than a year after premiering at Singapore’s MEDLAB Asia exhibition, X-ZELL’s Cryoimmunostaining™ Suite is now available in Europe (for Research Use Only). Originally designed to enable X-ZELL’s headline-making research into...

X-ZELL selected as finalist for Hello Tomorrow Singapore Challenge

Singapore, October 2019 – X-ZELL has been nominated as one of 16 regional finalists of the 2019 Hello Tomorrow Singapore Challenge. Hello Tomorrow is a global non-profit organisation on a mission to accelerate deep technology research and entrepreneurship, and to...

X-ZELL cancer detection technology on show at SWITCH X SSF 2019

Singapore, October 2019 – X-ZELL has been selected as one of the start-ups to be featured on A*ccelerate Technologies’ Innovation Pavilion at the upcoming SWITCH exhibition in Singapore. Short for Singapore Week of Innovation and Technology, SWITCH first came to life...

X-ZELL
Next-generation cytology

© 2024 X-ZELL Biotech Pte. Ltd.

Find Us

XZELL HQ